Patents by Inventor Kanji SUGITA

Kanji SUGITA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10314834
    Abstract: According to the present invention, there is provided a pharmaceutical composition for treating Philadelphia chromosome positive lymphocytic leukemia, including a thalidomide derivative and BCR-ABL tyrosine kinase inhibitor. According to the present invention there is also provided a method of treating Philadelphia chromosome positive lymphocytic leukemia, including administering a thalidomide derivative and a BCR-ABL tyrosine kinase inhibitor to a patient suffering from Philadelphia chromosome positive lymphocytic leukemia.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: June 11, 2019
    Assignees: UNIVERSITY OF YAMANASHI, TOKAI UNIVERSITY EDUCATIONAL SYSTEM
    Inventors: Kanji Sugita, Kiyoshi Ando
  • Publication number: 20180243284
    Abstract: According to the present invention, there is provided a pharmaceutical composition for treating Philadelphia chromosome positive lymphocytic leukemia, including a thalidomide derivative and BCR-ABL tyrosine kinase inhibitor. According to the present invention there is also provided a method of treating Philadelphia chromosome positive lymphocytic leukemia, including administering a thalidomide derivative and a BCR-ABL tyrosine kinase inhibitor to a patient suffering from Philadelphia chromosome positive lymphocytic leukemia.
    Type: Application
    Filed: September 9, 2016
    Publication date: August 30, 2018
    Applicants: UNIVERSITY OF YAMANASHI, TOKAI UNIVERSITY EDUCATIONAL SYSTEM
    Inventors: Kanji SUGITA, Kiyoshi ANDO